拯救卡文迪什

IF 33.1 1区生物学 Q1 BIOTECHNOLOGY & APPLIED MICROBIOLOGY

Nature biotechnology Pub Date : 2024-04-17 DOI:10.1038/s41587-024-02206-2

Claire Turrell

引用次数: 0

摘要

农民可以种植第一种转基因香蕉了。昆士兰科技大学（Queensland University of Technology）的研究人员开发的卡文迪许香蕉抗枯萎病菌株可抵抗毁灭性真菌巴拿马病（镰刀菌枯萎病）。澳大利亚基因技术监管办公室于 2 月 12 日批准转基因香蕉进行商业化种植。这种香蕉经过改良，能够抵御热带第 4 种族（TR4）真菌 Fusarium oxysporum f. sp. cubense，这是一种土壤传播的病原体，会侵袭香蕉根部，导致香蕉枯萎。这种真菌具有侵袭性和破坏性，已蔓延到全球多个国家。抗枯萎病香蕉的出现源于一次偶然的观察。昆士兰州的科学家注意到，一种野生品种（Musa acuminata ssp. malaccensis）香蕉在被该病肆虐的种植园中茁壮成长。虽然 malaccensis 香蕉因果肉太少、产量低而未被用于商业用途，但其 RGA2 基因的某些变异（卡文迪许品系中也有该基因，但没有活性）使其能够抵抗真菌。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

Saving Cavendish

查看原文本刊更多论文

Saving Cavendish

求助全文

通过发布文献求助，成功后即可免费获取论文全文。去求助

来源期刊

Nature biotechnology 工程技术-生物工程与应用微生物

CiteScore

63.00

自引率

1.70%

发文量

382

审稿时长

3 months

期刊介绍： Nature Biotechnology is a monthly journal that focuses on the science and business of biotechnology. It covers a wide range of topics including technology/methodology advancements in the biological, biomedical, agricultural, and environmental sciences. The journal also explores the commercial, political, ethical, legal, and societal aspects of this research. The journal serves researchers by providing peer-reviewed research papers in the field of biotechnology. It also serves the business community by delivering news about research developments. This approach ensures that both the scientific and business communities are well-informed and able to stay up-to-date on the latest advancements and opportunities in the field. Some key areas of interest in which the journal actively seeks research papers include molecular engineering of nucleic acids and proteins, molecular therapy, large-scale biology, computational biology, regenerative medicine, imaging technology, analytical biotechnology, applied immunology, food and agricultural biotechnology, and environmental biotechnology. In summary, Nature Biotechnology is a comprehensive journal that covers both the scientific and business aspects of biotechnology. It strives to provide researchers with valuable research papers and news while also delivering important scientific advancements to the business community.